These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30353031)

  • 1. IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability.
    Wang TT; Yang J; Zhang Y; Zhang M; Dubois S; Conlon KC; Tagaya Y; Hamele CE; Dighe S; Olson TL; Feith DJ; Azimi N; Waldmann TA; Loughran TP
    Leukemia; 2019 May; 33(5):1243-1255. PubMed ID: 30353031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.
    Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP
    Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia.
    Brammer JE; Ballen K; Sokol L; Querfeld C; Nakamura R; Mishra A; McLaughlin EM; Feith D; Azimi N; Waldmann TA; Tagaya Y; Loughran T
    Blood; 2023 Oct; 142(15):1271-1280. PubMed ID: 37352612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia.
    Zhang M; Mathews Griner LA; Ju W; Duveau DY; Guha R; Petrus MN; Wen B; Maeda M; Shinn P; Ferrer M; Conlon KD; Bamford RN; O'Shea JJ; Thomas CJ; Waldmann TA
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12480-5. PubMed ID: 26396258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21.
    Ciszewski C; Discepolo V; Pacis A; Doerr N; Tastet O; Mayassi T; Maglio M; Basheer A; Al-Mawsawi LQ; Green PHR; Auricchio R; Troncone R; Waldmann TA; Azimi N; Tagaya Y; Barreiro LB; Jabri B
    Gastroenterology; 2020 Feb; 158(3):625-637.e13. PubMed ID: 31622625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results From a First-in-Human Study of BNZ-1, a Selective Multicytokine Inhibitor Targeting Members of the Common Gamma (γc) Family of Cytokines.
    Frohna PA; Ratnayake A; Doerr N; Basheer A; Al-Mawsawi LQ; Kim WJ; Zapata JC; Wu X; Waldmann TA; Azimi N; Tagaya Y
    J Clin Pharmacol; 2020 Feb; 60(2):264-273. PubMed ID: 31465127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.
    Ju W; Zhang M; Jiang JK; Thomas CJ; Oh U; Bryant BR; Chen J; Sato N; Tagaya Y; Morris JC; Janik JE; Jacobson S; Waldmann TA
    Blood; 2011 Feb; 117(6):1938-46. PubMed ID: 21106989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and posttranslationally in ATL cells.
    Yamada O; Ozaki K; Akiyama M; Kawauchi K
    Mol Cancer Ther; 2012 May; 11(5):1112-21. PubMed ID: 22402124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D decreases STAT phosphorylation and inflammatory cytokine output in T-LGL leukemia.
    Olson KC; Kulling PM; Olson TL; Tan SF; Rainbow RJ; Feith DJ; Loughran TP
    Cancer Biol Ther; 2017 May; 18(5):290-303. PubMed ID: 27715403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
    Chetoui N; Boisvert M; Gendron S; Aoudjit F
    Immunology; 2010 Jul; 130(3):418-26. PubMed ID: 20465565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Matsuda T; Tanaka Y; Ohshiro K; Mori N
    Retrovirology; 2006 Apr; 3():22. PubMed ID: 16603085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways.
    de Totero D; Meazza R; Capaia M; Fabbi M; Azzarone B; Balleari E; Gobbi M; Cutrona G; Ferrarini M; Ferrini S
    Blood; 2008 Jan; 111(2):517-24. PubMed ID: 17938255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
    Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP
    PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.
    Girardi T; Vereecke S; Sulima SO; Khan Y; Fancello L; Briggs JW; Schwab C; de Beeck JO; Verbeeck J; Royaert J; Geerdens E; Vicente C; Bornschein S; Harrison CJ; Meijerink JP; Cools J; Dinman JD; Kampen KR; De Keersmaecker K
    Leukemia; 2018 Mar; 32(3):809-819. PubMed ID: 28744013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine release by activated T-cells in large granular lymphocytic leukemia associated with autoimmune disorders.
    Shvidel L; Duksin C; Tzimanis A; Shtalrid M; Klepfish A; Sigler E; Haran M; Eilat E; Berrebi A
    Hematol J; 2002; 3(1):32-7. PubMed ID: 11960393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.
    Waldmann TA; Chen J
    Annu Rev Immunol; 2017 Apr; 35():533-550. PubMed ID: 28182501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review].
    Qiu ZY; Fan Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):254-60. PubMed ID: 26913432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex.
    Rafei M; Wu JH; Annabi B; Lejeune L; François M; Galipeau J
    Blood; 2007 Mar; 109(5):2234-42. PubMed ID: 17082320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.